Literature DB >> 20842513

Evaluation of current therapeutic strategies in Behçet's disease.

Iliana Alexoudi1, Violetta Kapsimali, Aristides Vaiopoulos, Meletios Kanakis, George Vaiopoulos.   

Abstract

Behçet's disease (BD) is a chronic relapsing vasculitis with multifunctional pathogenesis. The mucocutaneous and ocular lesions are the commonest manifestations, but BD also affects the musculoskeletal, intestinal, cardiac, and central nervous system. BD therapy is based on the suppression of the inflammatory process, using immunomodulating and immunosuppressive agents. In selected cases, invasive procedures may be required.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20842513     DOI： 10.1007/s10067-010-1566-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  49 in total

Review 1.  Behçet's disease: recent advances in early diagnosis and effective treatment.

Authors:  Kenneth T Calamia; Phaedon G Kaklamanis
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 2.  Behçet's disease: an algorithmic approach to its treatment.

Authors:  Erkan Alpsoy; Ayse Akman
Journal:  Arch Dermatol Res       Date:  2009-08-21       Impact factor: 3.017

3.  Behçet's disease as a frequently unrecognized cause of aortic regurgitation: suggestive and misleading echocardiography findings.

Authors:  Jung-Kyu Han; Hyung-Kwan Kim; Yong-Jin Kim; Goo-Yeong Cho; Myung-A Kim; Dae-Won Sohn; Young-Bae Park
Journal:  J Am Soc Echocardiogr       Date:  2009-09-18       Impact factor: 5.251

Review 4.  The management of Behçet's syndrome.

Authors:  Emire Seyahi; Izzet Fresko; Melike Melikoglu; Hasan Yazici
Journal:  Acta Reumatol Port       Date:  2006 Apr-Jun       Impact factor: 1.290

5.  Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction.

Authors:  S M Debol; M J Herron; R D Nelson
Journal:  J Leukoc Biol       Date:  1997-12       Impact factor: 4.962

Review 6.  Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations.

Authors:  Violetta D Kapsimali; Meletios A Kanakis; George A Vaiopoulos; Phaedon G Kaklamanis
Journal:  Clin Rheumatol       Date:  2010-05-22       Impact factor: 2.980

7.  Behçet disease: treatment of vascular involvement in children.

Authors:  Seza Ozen; Yelda Bilginer; Nesrin Besbas; Nuray Aktay Ayaz; Aysin Bakkaloglu
Journal:  Eur J Pediatr       Date:  2009-09-13       Impact factor: 3.183

8.  Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

Authors:  Lothar Krause; Andreas Altenburg; Uwe Pleyer; Anne-Katrin Köhler; Christos C Zouboulis; Michael H Foerster
Journal:  J Rheumatol       Date:  2008-04-15       Impact factor: 4.666

Review 9.  Treatment of neuro-Behçet's disease: an update.

Authors:  Afshin Borhani Haghighi
Journal:  Expert Rev Neurother       Date:  2009-04       Impact factor: 4.618

Review 10.  Major arterial involvement and review of Behcet's disease.

Authors:  Ufuk Alpagut; Murat Ugurlucan; Enver Dayioglu
Journal:  Ann Vasc Surg       Date:  2007-03       Impact factor: 1.466
View more
  9 in total

1.  Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study.

Authors:  Giacomo Emmi; Rosaria Talarico; Giuseppe Lopalco; Rolando Cimaz; Fabrizio Cantini; Ombretta Viapiana; Ignazio Olivieri; Matteo Goldoni; Antonio Vitale; Elena Silvestri; Domenico Prisco; Giovanni Lapadula; Mauro Galeazzi; Florenzo Iannone; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-07-10       Impact factor: 2.980

2.  Anakinra treatment in drug-resistant Behcet's disease: a case series.

Authors:  Luca Cantarini; Antonio Vitale; Perla Scalini; Charles A Dinarello; Donato Rigante; Rossella Franceschini; Gabriele Simonini; Giulia Borsari; Francesco Caso; Orso Maria Lucherini; Bruno Frediani; Ilaria Bertoldi; Leonardo Punzi; Mauro Galeazzi; Rolando Cimaz
Journal:  Clin Rheumatol       Date:  2013-12-05       Impact factor: 2.980

Review 3.  Hughes-Stovin syndrome.

Authors:  Umair Khalid; Taimur Saleem
Journal:  Orphanet J Rare Dis       Date:  2011-04-13       Impact factor: 4.123

4.  New Evidence-Based Treatment Approach in Behçet's Disease.

Authors:  Erkan Alpsoy
Journal:  Patholog Res Int       Date:  2011-10-05

5.  New insights in the clinical understanding of Behçet's disease.

Authors:  Sung Bin Cho; Suhyun Cho; Dongsik Bang
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

6.  Development of Immunopathogenesis Strategies to Treat Behçet's Disease.

Authors:  Osman Köse
Journal:  Patholog Res Int       Date:  2012-04-03

7.  Thrombosis in vasculitis: from pathogenesis to treatment.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Amedeo Amedei; Elena Niccolai; Mario Milco D'Elios; Chiara Della Bella; Alessia Grassi; Matteo Becatti; Claudia Fiorillo; Lorenzo Emmi; Augusto Vaglio; Domenico Prisco
Journal:  Thromb J       Date:  2015-04-16

8.  Pulmonary artery aneurysm: Harbinger of an ominous disease.

Authors:  Deepanjan Bhattacharya; Deepa Sasikumar; Ayyappan Anoop; Jineesh Valakada; Nitin Naik; Baiju Sasi Dharan
Journal:  Ann Pediatr Cardiol       Date:  2022-06-14

9.  Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.

Authors:  Robert J Barry; Bharat Markandey; Rahul Malhotra; Henry Knott; Nikita Joji; Mohammed Mubin; Alastair K Denniston; Phillip I Murray
Journal:  Orphanet J Rare Dis       Date:  2014-01-30       Impact factor: 4.123
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.